China-based Raybow USA Expands Brevard, North Carolina, Campus
The $15.8 million project is expected to create 74 jobs over the coming five years. The company, which currently employs 24 in Brevard, focuses on early-stage R&D and process research through Phase II clinical trials.
Peter Halkjaer-Knudsen, Executive Vice President of Raybow Pharmaceuticals said, "Raybow Pharmaceuticals is proud to announce that, a year since we acquired the Brevard site, we are ready to further increase our commitment in North Carolina. We are grateful for the warm welcome we have received and the continued support we experienced during the feasibility studies for this expansion. Transylvania County has proven to be the right choice for our North American headquarters and R&D operations and we very much look forward to the continued journey with the people of North Carolina."
New positions at Raybow USA will include research chemists, pilot-plant personnel and supervisors. Once the expansion is complete, the local region will benefit from a nearly $5.7 million payroll impact in the community, each and every year.
"North Carolina pioneered contract pharmaceutical discovery more than a generation ago, and today the industry connects many of our communities with global life sciences opportunities," said Commerce Secretary Machelle Sanders. "We welcome this major expansion by Raybow USA, whose local roots showcase the best traditions of entrepreneurship in our state."
The company was founded as PharmAgra Labs in 1999 by two North Carolina entrepreneurs. Today, the Brevard-based company is a publicly-held contract development and manufacturing organization that partners with leading pharmaceutical companies across Asia, Europe and North America.
2023's Leading Metro Locations: Hotspots of Economic Growth
The Logistics Analysis That Drives Industrial Site Selection
2023 Top States for Doing Business Meet the Needs of Site Selectors
Technology’s Influence on Workforce Development
Workforce Q4 2023
AI 101 for Site Selection
First Person: Realizing the Inflation Reduction Act’s Full Potential
2023 Top States Commentary: Top-Ranked States Have What It Takes to Win Mega Projects